Image may be NSFW.
Clik here to view.
Clik here to view.
Isotechnika gets more funding for NICAM program
Isotechnika Pharma (TSX: ISA) has received additional funding from the National Research Council Industrial Research Assistance Program (NRC-IRAP) for its non-immunosuppressive cyclophilin antagonist...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Ciclofilin gets Japanese patent for inhibitor drugs
Closely-held Ciclofilin Pharmaceuticals has been issued a patent in Japan for its cyclophilin inhibitor drugs entitled, “Nonimmunosuppressive Cyclosporine Analogue Molecules.” The company’s lead...
View Article
More Pages to Explore .....
